Barrington Research Reiterates Volcano Outperform, $31 PT

Barrington Research reiterated its Volcano VOLC Outperform rating and $31 price target in a research report published today. In the report, Barrington Research states, "We are reiterating our OUTPERFORM rating and $31 price target based on our belief that the clinical evidence is building for VOLC's IVUS and FM technology to be standard of care for a large percentage of the millions of worldwide PCI procedures." Shares of Volcano were trading at $28.84 at the time of posting, up 2.27% from Friday's market close.